A detailed history of Signal Advisors Wealth, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Signal Advisors Wealth, LLC holds 901 shares of LLY stock, worth $673,957. This represents 0.11% of its overall portfolio holdings.

Number of Shares
901
Previous 328 174.7%
Holding current value
$673,957
Previous $297 Million 168.65%
% of portfolio
0.11%
Previous 0.65%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$772.14 - $960.02 $442,436 - $550,091
573 Added 174.7%
901 $798 Million
Q2 2024

Jul 22, 2024

SELL
$724.87 - $909.04 $496,535 - $622,692
-685 Reduced 67.62%
328 $297 Million
Q1 2024

Apr 09, 2024

BUY
$592.2 - $792.28 $111,333 - $148,948
188 Added 22.79%
1,013 $788 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $433,281 - $510,782
825 New
825 $481 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Signal Advisors Wealth, LLC Portfolio

Follow Signal Advisors Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signal Advisors Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signal Advisors Wealth, LLC with notifications on news.